Dynamic contrast-enhanced MRI is now established as the methodology of choice for the assessment of tumor microcirculation in vivo. This is assisting clinical practitioners in the management of patients with solid tumors and is finding prominence in the assessment of tumor treatments, including anti-angiogenics, chemotherapy, and radiotherapy. In this book, targeted at both clinical practitioners and basic scientists, the principles of the methods, their practical implementation, and their application to specific tumor types are discussed by the leading authorities in the field today. The book will serve as an invaluable single-volume reference covering all the latest developments in contrast-enhanced oncological MRI.

Principles of Dynamic Contrast-Enhanced MRI

An Introduction to Dynamic Contrast-Enhanced MRI in Oncology
Contrast Agents for Magnetic Resonance Imaging
The Role of Blood Pool Contrast Media in the Study of Tumor Pathophysiology
Quantification of Dynamic Susceptibility Contrast T2* MRI in Oncology
Measuring Contrast Agent Concentration in T1-Weighted Dynamic Contrast-Enhanced MRI
Tracer Kinetic Modelling for T1-Weighted DCE-MRI
Imaging Techniques
Imaging Techniques for Dynamic Susceptibility Contrast-Enhanced MRI
Consensus Recommendations for Acquisition of Dynamic Contrasted-Enhanced MRI Data in Oncology
Clinical Applications
Dynamic Contrast-Enhanced MRI in Cerebral Tumours
Dynamic Magnetic Resonance Imaging in Breast Cancer
Dynamic Contrast-Enhanced MR Imaging for Predicting Tumor Control in Patients with Cervical Cancer
Dynamic Contrast-Enhanced MRI of Prostate Cancer
Dynamic Contrast-Enhanced MR Imaging in Musculoskeletal Tumors
Dynamic Contrast-Enhanced MRI in the Liver
Applications
Use of Dynamic Contrast-Enhanced MRI in Multi-Centre Trials with Particular Reference to Breast Cancer Screening in Women at Genetic Risk
Applications of Dynamic Contrast-Enhanced MRI in Oncology Drug Development.